Focus 

Soft Tissue

The heterogeneity and relative rarity of soft tissue sarcomas make them challenging targets for classification, biomarker identification, and development of improved treatment strategies. Laboratory Investigation and Modern Pathology are pleased to present a collection of recent articles that enhance our understanding of the pathogenesis of these tumors and describe advances that may lead to the development of new diagnostic tests and targeted therapies.

Content